Please check your internet connection and try again.
# Clobazam (Oral Formulation)
## Overview
Clobazam is a benzodiazepine derivative with anticonvulsant properties. It is used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS) and other seizure types.
## Primary Indications
* Adjunctive treatment of seizures in patients with Lennox-Gastaut syndrome (LGS).
* May be used for other seizure types where adjunctive benzodiazepine therapy is appropriate.
## Adult Dosing
* **Lennox-Gastaut Syndrome (LGS):**
* Initiation: 5 mg twice daily.
* Maintenance: Gradually titrate by 5-10 mg every week based on clinical response and tolerability.
* Maximum dose: 20 mg twice daily.
* **Other Seizure Types:** Dosing varies. Consult specific guidelines or product labeling. Generally, lower doses are used compared to LGS.
## Pediatric Dosing
* **Lennox-Gastaut Syndrome (LGS):**
* Patients 2 to less than 10 years of age:
* Initiation: 2.5 mg twice daily.
* Maintenance: Gradually titrate by 2.5-5 mg every week based on clinical response and tolerability.
* Maximum dose: 10 mg twice daily.
* Patients 10 years of age and older: Initiate and titrate as per adult dosing recommendations, with a maximum dose of 20 mg twice daily.
* **General Pediatric Considerations:** For children under 2 years of age or weighing less than 30 kg, use with caution and at the lowest effective dose due to increased risk of adverse effects. Specific dosing for this population may be highly individualized and depend on local protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary.
* **Renal Impairment:** Use with caution. Dose reduction may be necessary, especially in severe impairment.
* **Concomitant Medications:** Caution with CYP3A4 inhibitors or inducers; dose adjustments may be required.
## Contraindications
* Known hypersensitivity to clobazam or other benzodiazepines.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Severe muscle weakness (myasthenia gravis).
* Acute narrow-angle glaucoma.
## Adverse Effects
* **Common:** Somnolence, decreased appetite, constipation, aggression, irritability, difficulty speaking, abnormal coordination, falls, fatigue, drowsiness, rash, behavioral changes (especially in children).
* **Serious:** Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), respiratory depression, dependence and withdrawal symptoms, suicidal behavior or ideation, paradoxical reactions (increased seizures, agitation).
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Additive CNS depression, increased risk of sedation, respiratory depression, and coma.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase clobazam concentrations. Consider dose reduction.
* **CYP3A4 Inducers (e.g., rifampin, carbamazepine):** May decrease clobazam concentrations. Consider dose increase.
* **Antiepileptic Drugs (AEDs):** Potential for additive sedation. Monitor for increased adverse effects.
* **Stimulants:** May reduce the efficacy of clobazam.
## Monitoring
* Seizure frequency and type.
* Signs of CNS depression (sedation, dizziness).
* Behavioral changes, particularly in pediatric patients.
* Signs of dependence and withdrawal.
* Skin reactions.
* Liver and renal function tests periodically, especially with long-term use or in patients with pre-existing impairment.
## Clinical Pearls
* Taper clobazam slowly when discontinuing to avoid withdrawal symptoms.
* Clobazam can cause significant somnolence; advise patients to avoid driving or operating heavy machinery until they know how the medication affects them.
* Behavioral changes, including aggression and irritability, are more commonly reported in children.
* Consider potential for drug interactions, especially with concomitant AEDs and CYP3A4-metabolized drugs.
* The risk of serious skin reactions, while rare, necessitates prompt discontinuation if they occur.
***
*Disclaimer: This information is intended for clinical use and does not replace professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions.*
